Assessment of Therapeutic Effect of Sunitinib by $^{11}C$-Acetate PET Compared with FDG PET Imaging in a Patient with Metastatic Renal Cell Carcinoma

Assessment of Therapeutic Effect of Sunitinib by $^{11}C$-Acetate PET Compared with FDG PET Imaging in a Patient with Metastatic Renal Cell Carcinoma
Assessment of Therapeutic Effect of Sunitinib by $^{11}C$-Acetate PET Compared with FDG PET Imaging in a Patient with Metastatic Renal Cell Carcinoma

ㆍ 저자명: Oyama. Nobuyuki,Takahara. Noriko,Hasegawa. Yoko,Tanase. Kazuya,Miwa. Yoshiji,Akino. Hironobu,Okazawa. Hidehiko,Kudo. Takashi,Fuj
ㆍ 간행물명: Nuclear medicine and molecular imaging : NMMI
ㆍ 권/호정보: 2011년|45권 3호|pp.217-219 (3 pages)
ㆍ 발행정보: 대한핵의학회
ㆍ 파일정보: 정기간행물|ENG|
PDF텍스트
ㆍ 주제분야: 기타

이 논문은 한국과학기술정보연구원과 논문 연계를 통해 무료로 제공되는 원문입니다.

서지반출

기타언어초록

Although sunitinib shows a high response rate in patients with untreated metastatic renal cell carcinoma (mRCC), quite a few patients show no therapeutic effect. Therefore, it is crucial to distinguish the patients who respond to sunitinib from those who do not as early as possible after the administration of the therapy. We herein report a case of mRCC in which $^{11}C$-acetate (AC) positron emission tomography (PET) showed an early therapeutic effect of sunitinib treatment 4 weeks after its administration.

키워드

$^{11}C$-acetate Positron emission tomography Therapeutic effect Renal cell carcinoma Sunitinib

다운URL